Browsing Tag
GLP-1
9 posts
Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients
A recent study published in the New England Journal of Medicine conducted a trial of lixisenatide to assess…
Popular diabetes drugs not linked to thyroid cancer risk, study finds
Drugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been…
AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills
Two plant compounds with potential as GLP-1 agonist weight loss pills have been identified in an AI (artificial…
New research sheds light on how GLP-1 obesity drugs may change food cravings
In a recent review published in the International Journal of Obesity, researchers explored the potential of glucagon-like peptide-1…
Diabetes drug dulaglutide may reduce symptoms of depression
A recent Brain and Behavior study investigated the antidepressant effect of dulaglutide and the mechanism that underlies this effect. Study:…
Study reveals mechanisms behind antidepressant effects of diabetes drug
Research in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist…
Gut bacteria diversity linked to body weight, athletes show healthier profiles
In the last decade, an increasing number of studies have been conducted to establish the relationship between gut…
New weight loss drug may be an effective strategy for preventing or treating high blood pressure
The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood…
Breakthrough obesity treatments on the horizon, rivaling surgery’s success
In a recent study published in the International Journal of Obesity, researchers discussed the pipeline of obesity pharmacotherapies.…